Trends in Biotechnology

Papers
(The H4-Index of Trends in Biotechnology is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Subscription and Copyright information284
Advisory Board and Contents279
Vector-free intra-airway in vivo epigenetic editing167
Bridging the path to multiplexed molecular diagnostics163
Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models142
Vibrio natriegens as a host for rapid biotechnology140
Electronic plants: the future of agriculture and urban ecosystems?140
SynMADE: synthetic microbiota across diverse ecosystems133
Auricular repair: symphony between scaffolds and stem cells130
Manipulating immune activity of macrophages: a materials and mechanics perspective116
(R)evolution-on-a-chip108
The green revolution of food waste upcycling to produce polyhydroxyalkanoates104
Analyzing and understanding the robustness of bioprocesses102
Engineering biology approaches to modulate bacterial biofilms99
Microalgae: a revolution for salt-affected soil remediation97
Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications96
Phytohormones: novel strategy for removing emerging contaminants and recovering resources96
Prime editing: advances and therapeutic applications89
Healing wounds with plasma-activated hydrogel therapy88
Smart materials: rational design in biosystems via artificial intelligence85
Enzyme discovery and engineering for sustainable plastic recycling82
Advisory Board and Contents82
Subscription and Copyright information81
Subscription and Copyright information80
UFSC Biotech Network: a transdisciplinary platform for biotechnology innovation in Brazil76
Subscription and Copyright information76
The GPS for drug development: navigating with evidence from human populations75
Advisory Board and Contents74
Manufacturing innovation to drive down cell therapy costs72
Nanobotic microbiomes against emerging vascular pathogens in agriculture72
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases71
Beyond waste: understanding urine’s potential in precision medicine70
Towards biomanufacturing of cultured meat70
Extended human lymph node explants for evaluation of adaptive immunity68
A high-performance protein preparation approach in a single column-free step68
Molecular design of microalgae as sustainable cell factories67
Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions66
Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia65
Can protein expression be ‘solved’?65
Machine learning to predict de novo protein–protein interactions65
Multiscale models quantifying yeast physiology: towards a whole-cell model64
Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis64
Printhead on a chip: empowering droplet-based bioprinting with microfluidics63
Next-generation digital biomarkers: continuous molecular health monitoring using wearable devices63
Mini-bones: miniaturized bone in vitro models62
Machine learning in bioprocess development: from promise to practice62
Translational organoid technology – the convergence of chemical, mechanical, and computational biology62
Advisory Board and Contents61
Emerging strategies to develop novel genetically encoded biosensors61
Subscription and Copyright information59
Next-generation 3D-printed nutritious food derived from waste plastic and biomass59
Improving awareness, understanding, and enforcement of responsibilities and regulations in Blue Biotechnology58
The LEGO® brick road to open science and biotechnology57
Sebum analysis as an advantageous source of biomolecular information56
3D extrusion bioprinting: rational bioink design and advanced fabrication techniques56
Dynamically regulating metabolic fluxes with synthetic metabolons55
Advisory Board and Contents55
0.071964025497437